EA200701399A1 - Сульфоны трипептидов и тетрапептидов - Google Patents

Сульфоны трипептидов и тетрапептидов

Info

Publication number
EA200701399A1
EA200701399A1 EA200701399A EA200701399A EA200701399A1 EA 200701399 A1 EA200701399 A1 EA 200701399A1 EA 200701399 A EA200701399 A EA 200701399A EA 200701399 A EA200701399 A EA 200701399A EA 200701399 A1 EA200701399 A1 EA 200701399A1
Authority
EA
Eurasian Patent Office
Prior art keywords
bone marrow
cells
трипептидов
тетрапептидов
сульфоны
Prior art date
Application number
EA200701399A
Other languages
English (en)
Inventor
Стивен Р. Шоу
Наталия Ауррекоечеа
Original Assignee
Телик, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Телик, Инк. filed Critical Телик, Инк.
Publication of EA200701399A1 publication Critical patent/EA200701399A1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0215—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing natural amino acids, forming a peptide bond via their side chain functional group, e.g. epsilon-Lys, gamma-Glu
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

В заявке описаны сульфоны трипептидов и тетрапептидов, содержащие их фармацевтические композиции, их применение в фармакологии и их получение. Соединения применяют для потенцирования цитотоксического действия химиотерапевтических агентов в опухолевых клетках, избирательного стимулирования токсичности в опухолевых клетках, повышения уровня образования клеток-предшественников GM в костном мозге, стимулирования дифференциации клеток костного мозга, уменьшения разрушительного действия химиотерапевтических агентов на костный мозг и модуляции кроветворения в костном мозге.
EA200701399A 2005-01-06 2006-01-05 Сульфоны трипептидов и тетрапептидов EA200701399A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US64193205P 2005-01-06 2005-01-06
PCT/US2006/000532 WO2006074409A1 (en) 2005-01-06 2006-01-05 Tripeptide and tetrapeptide sulfones

Publications (1)

Publication Number Publication Date
EA200701399A1 true EA200701399A1 (ru) 2008-02-28

Family

ID=36123437

Family Applications (2)

Application Number Title Priority Date Filing Date
EA200701398A EA200701398A1 (ru) 2005-01-06 2006-01-04 Тиоэфиры трипептидов и тетрапептидов
EA200701399A EA200701399A1 (ru) 2005-01-06 2006-01-05 Сульфоны трипептидов и тетрапептидов

Family Applications Before (1)

Application Number Title Priority Date Filing Date
EA200701398A EA200701398A1 (ru) 2005-01-06 2006-01-04 Тиоэфиры трипептидов и тетрапептидов

Country Status (25)

Country Link
US (2) US7129215B2 (ru)
EP (2) EP1833978B1 (ru)
JP (2) JP4903716B2 (ru)
KR (2) KR101244609B1 (ru)
CN (2) CN101090977B (ru)
AR (2) AR051889A1 (ru)
AT (2) ATE410520T1 (ru)
AU (2) AU2006204022B2 (ru)
BR (2) BRPI0606520A2 (ru)
CA (2) CA2587284C (ru)
DE (2) DE602006003064D1 (ru)
DK (2) DK1833978T3 (ru)
EA (2) EA200701398A1 (ru)
ES (2) ES2314890T3 (ru)
HK (2) HK1106796A1 (ru)
HR (2) HRP20090128T3 (ru)
IL (2) IL182836A (ru)
MX (2) MX2007008255A (ru)
NZ (2) NZ555362A (ru)
PL (2) PL1833978T3 (ru)
PT (2) PT1833978E (ru)
SI (2) SI1833978T1 (ru)
TW (2) TWI317739B (ru)
WO (2) WO2006074249A1 (ru)
ZA (2) ZA200704487B (ru)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8198247B2 (en) 2004-12-21 2012-06-12 Telik, Inc. Process for and intermediates in the preparation of canfosfamide and its salts
SI1833978T1 (sl) * 2005-01-06 2009-04-30 Telik Inc Tripeptidni in tetrapeptidni tioetri
US20070154963A1 (en) * 2005-12-30 2007-07-05 Danying Cai Method to determine whether a compound is a cellular GSTpi inhibitor
US20090221703A1 (en) 2006-07-09 2009-09-03 Chongxi Yu High penetration composition and uses thereof
US20090238763A1 (en) 2006-07-09 2009-09-24 Chongxi Yu High penetration compositions and uses thereof
AU2016213759B2 (en) * 2006-11-08 2018-03-29 Chongxi Yu Transdermal delivery systems of peptides and related compounds
CN101541743A (zh) * 2006-11-08 2009-09-23 于崇曦 多肽及相关化合物的透皮给药系统
CN105820107B (zh) 2007-06-04 2022-09-09 泰飞尔公司 具有快速皮肤和生物膜穿透速度的非甾体抗炎药的前药及其新的医药用途
KR20200022525A (ko) 2008-12-04 2020-03-03 충시 위 고투과력을 가진 조성물 및 이의 적용
DE102008060888A1 (de) 2008-12-09 2010-06-10 Evonik Stockhausen Gmbh Verfahren zur Herstellung von Acrolein umfassend die Aufarbeitung einer Rohglycerin-Phase
CN108084246A (zh) 2009-05-08 2018-05-29 上海泰飞尔生化技术有限公司 多肽和多肽相关化合物的高穿透力前药组合物
JP2013528214A (ja) 2010-06-07 2013-07-08 テリック，インコーポレイテッド 結晶性エザチオスタット塩酸塩非溶媒和物ｄ型の調製
EP2576591A2 (en) * 2010-06-07 2013-04-10 Telik, Inc. Tablet formulation of ezatiostat
US20130035389A1 (en) * 2011-08-05 2013-02-07 Telik, Inc. Methods for treating myelodysplastic syndrome with ezatiostat
JP5970439B2 (ja) * 2013-09-20 2016-08-17 チョンシー ユー ペプチド及び関連化合物の経皮送達システム
CN106146616A (zh) * 2015-04-03 2016-11-23 浙江海正药业股份有限公司 环肽类化合物及其制备和用途

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5599903A (en) * 1992-04-03 1997-02-04 Terrapin Technologies, Inc. Glutathione analogs and paralog panels comprising glutathione mimics
US5786336A (en) 1991-04-29 1998-07-28 Terrapin Technologies, Inc. Target-selective protocols based on mimics
US5556942A (en) * 1991-04-29 1996-09-17 Terrapin Technologies, Inc. Glutathione S-transferase-activated compounds
US5767086A (en) * 1992-04-03 1998-06-16 Terrapin Technologies, Inc. Bone marrow stimulation by certain glutathione analogs
US5955432A (en) * 1992-04-03 1999-09-21 Terrapin Technologies, Inc. Metabolic effects of certain glutathione analogs
CA2105492C (en) * 1993-09-03 2000-02-01 Lawrence M. Kauvar Glutathione analogs and paralog panels comprising glutathione mimics
US5908919A (en) * 1993-10-01 1999-06-01 Terrapin Technologies Urethane mediated, GST specific molecular release systems
DK0831877T3 (da) 1995-06-07 2005-02-14 Telik Inc Metabolske virkninger af visse glutathionanaloge
WO1998009986A1 (en) * 1996-09-02 1998-03-12 The Manchester Metropolitan University S-blocked glutathiones
KR20010042752A (ko) * 1998-04-16 2001-05-25 야스이 쇼사꾸 글루타티온 유도체 및 이의 투여 형태
JP2002535359A (ja) 1999-01-27 2002-10-22 テリック，インコーポレイテッド グルタチオン類縁体を含有する治療用組成物
US7029695B2 (en) * 2001-07-10 2006-04-18 Telik, Inc. Therapeutic compositions containing glutathione analogs
TWI323662B (en) * 2002-11-15 2010-04-21 Telik Inc Combination cancer therapy with a gst-activated anticancer compound and another anticancer therapy
SI1833978T1 (sl) * 2005-01-06 2009-04-30 Telik Inc Tripeptidni in tetrapeptidni tioetri

Also Published As

Publication number Publication date
EP1833978B1 (en) 2008-10-08
IL183107A0 (en) 2007-09-20
JP4903716B2 (ja) 2012-03-28
AR051890A1 (es) 2007-02-14
ZA200704488B (en) 2008-09-25
CN101080418A (zh) 2007-11-28
NZ555361A (en) 2009-05-31
CA2587284A1 (en) 2006-07-13
ES2314891T3 (es) 2009-03-16
HRP20090128T3 (en) 2009-04-30
TWI317739B (en) 2009-12-01
EP1833842B1 (en) 2008-10-08
ATE410520T1 (de) 2008-10-15
MX2007008254A (es) 2007-09-11
TW200635948A (en) 2006-10-16
MX2007008255A (es) 2007-09-11
NZ555362A (en) 2009-05-31
EA200701398A1 (ru) 2007-12-28
AR051889A1 (es) 2007-02-14
IL182836A (en) 2010-11-30
EP1833978A1 (en) 2007-09-19
AU2006203901A1 (en) 2006-07-13
US20060148719A1 (en) 2006-07-06
US7192918B2 (en) 2007-03-20
ATE410440T1 (de) 2008-10-15
PT1833978E (pt) 2008-12-02
PL1833842T3 (pl) 2009-04-30
AU2006204022A1 (en) 2006-07-13
HK1106796A1 (en) 2008-03-20
BRPI0606520A2 (pt) 2009-06-30
US7129215B2 (en) 2006-10-31
KR20070091611A (ko) 2007-09-11
CA2587310A1 (en) 2006-07-13
JP4903717B2 (ja) 2012-03-28
SI1833842T1 (sl) 2009-04-30
PT1833842E (pt) 2008-12-11
TWI317738B (en) 2009-12-01
WO2006074409A9 (en) 2006-12-14
KR101244609B1 (ko) 2013-03-25
WO2006074249A1 (en) 2006-07-13
SI1833978T1 (sl) 2009-04-30
BRPI0606396A2 (pt) 2009-06-23
AU2006203901B2 (en) 2011-06-02
CA2587310C (en) 2013-11-12
KR20070104391A (ko) 2007-10-25
JP2008526880A (ja) 2008-07-24
HK1106778A1 (en) 2008-03-20
WO2006074409A1 (en) 2006-07-13
JP2008526859A (ja) 2008-07-24
DE602006003064D1 (en) 2008-11-20
EP1833842A1 (en) 2007-09-19
DK1833978T3 (da) 2009-02-09
CA2587284C (en) 2014-03-25
IL182836A0 (en) 2007-08-19
AU2006204022B2 (en) 2011-01-20
ZA200704487B (en) 2008-09-25
CN101090977A (zh) 2007-12-19
DK1833842T3 (da) 2009-02-09
IL183107A (en) 2010-11-30
DE602006003063D1 (de) 2008-11-20
TW200635949A (en) 2006-10-16
HRP20090134T3 (en) 2009-04-30
US20060160749A1 (en) 2006-07-20
CN101090977B (zh) 2013-04-10
ES2314890T3 (es) 2009-03-16
PL1833978T3 (pl) 2009-04-30

Similar Documents

Publication Publication Date Title
EA200701399A1 (ru) Сульфоны трипептидов и тетрапептидов
ATE509634T1 (de) Pharmazeutische formulierungen mit incretin- peptid und aprotisch-polarem lösungsmittel
CY1115875T1 (el) Αντισωματα toy υποδοχεα 1 της ιντερφερονης αλφα και οι χρησεις αυτων
CL2007000161A1 (es) Compuestos derivados de 2,4-dioxoimidazolidina sustituida, inhibidores de proteinas cinasas; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como cancer.
CL2009000400A1 (es) Compuestos heterociclicos derivados de 3-fenil-1,6- naftiridin-2-ona; moduladores de la actividad cinasa; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como trastornos alergicos, trastornos autoinmunes, neoplasias, rechazo en trasplante de organos, entre otras.
ATE534290T1 (de) Apparat zur verlängerung der überlebensdauer von blutplättchen
EA200800100A1 (ru) Соединения азаиндазола и способы применения
SE0301653D0 (sv) Novel compounds
CO5660287A2 (es) Derivados de tetrahidrocarbazol y su uso farmaceutico
EA200700189A1 (ru) Производные хиназолина в качестве ингибиторов parp
BRPI0509369A (pt) azaindóis úteis como inibidores de jak e outras proteìna cinases
BRPI0607728A2 (pt) complexo de lipoproteìna carregado reconstituìdo, composição farmacêutica, e, uso de um complexo de lipoproteìna carregado
SG153800A1 (en) Pharmaceutical compositions
AR047928A1 (es) Derivados de tetrahidropiridoindol
EA200702320A1 (ru) Соединения trpv1 агониста и способы их получения и применения
ATE543491T1 (de) Kombinationspräparat enthaltend ibuprofen und paracetamol
CL2007001710A1 (es) Compuestos derivados de amino-pirazolopiridina sustituidos; metodo de preparacion; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como tumores, artritis reumatoide, enfermedades de crecimiento vascular desregulado, entre otras.
BRPI0519070A2 (pt) composiÇço de fator de crescimento de queratinàcito liofilizada, mÉtodos para preparar um fator de crescimento de queratinàcito liofilizado, e para tratar uma doenÇa, e, kit para preparar uma composiÇço farmacÊutica aquosa
NI200900079A (es) Novedosos anticuerpos antiproliferación.
MEP20908A (en) Thienopyrazoles
CY1109537T1 (el) Πεπτιδια και παραγωγα πεπτιδιου, παρασκευη αυτων καθως επισης χρηση αυτων για την παρασκευη θεραπευτικως η/και προληπτικως δραστικης φαρμακευτικης συνθεσης
CL2008000495A1 (es) Compuestos derivados de tetrahidro-pirazolo[4,3-c]piridina; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como alergias, inflamacion, dolor, cancer, entreotras.
ATE549353T1 (de) Aktive varianten des il-18 bindenden proteins und dessen medizinische verwendungen
UY29999A1 (es) "n-pirazinil-fenilsulfonamidas, procedimientos y compuestos intemedios utilizados en su preparacion, composiciones farmaceuticas que las contienen y aplicaciones"
PL1868631T3 (pl) Zastosowanie związków indukujących syntezę białek SIRT przy lub dla otrzymywania kompozycji kosmetycznej lub farmaceutycznej